WALTHAM, Mass.--(EON: Enhanced Online News)--Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the University College London (UCL) School of Pharmacy today announced publishing a new book, The School of Pharmacy, University of London: Medicines, Science and Society, 1842-2012, authored by Briony Hudson in collaboration with Maureen Boylan. Its publication marks the 170th anniversary of the School of Pharmacy and its transition from the University of London to UCL.
“Given that we both serve this market, we felt it was important to capture the history of this school which has made such noteworthy contributions to the pharmacy profession.”
The book details the chronological history of the school from its establishment in 1842 to present day, and discusses the school’s future aspirations. It presents the history of the school uniquely within the context of the development of the pharmacy profession and educational systems, pharmacists’ changing relationships with their patients, and the evolving fields of medicine and public health.
“This new book is the wonderful result of our collaboration with the prestigious University of London on a project that commemorates the history of its School of Pharmacy,” said Suzanne BeDell, Managing Director, Science and Technology Books at Elsevier. “Given that we both serve this market, we felt it was important to capture the history of this school which has made such noteworthy contributions to the pharmacy profession.”
The School of Pharmacy, University of London uses numerous photographs, discussions of important industry advances, cultural milestones, and biographies to portray the history of the school. It celebrates the heritage of the school and highlights its cutting-edge role in pharmacy innovation, research and education. The book also features a foreword written by Her Royal Highness, Princess Anne, Chancellor of the University of London.
Complimentary access to the ebook is available to ScienceDirect subscribers through sponsorship by the University of London. ScienceDirect is Elsevier’s full-text scientific database offering journal articles and book chapters from more than 2,500 peer-reviewed journals and nearly 20,000 book titles.
The book is also available through the Elsevier Store.
About UCL (University College London)
Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender and the first to provide systematic teaching of law, architecture and medicine.
We are among the world's top universities, as reflected by our performance in a range of international rankings and tables. According to the Thomson Scientific Citation Index, UCL is the second most highly cited European university and the 15th most highly cited in the world.
UCL has nearly 27,000 students from 150 countries and more than 9,000 employees, of whom one third are from outside the UK. The university is based in Bloomsbury in the heart of London, but also has two international campuses – UCL Australia and UCL Qatar. Our annual income is more than £800 million.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).